KPC Pharmaceuticals Inc (600422) — Cash Flow-to-Debt Ratio
KPC Pharmaceuticals Inc (600422) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of CN¥113.07 Million could theoretically repay 0% of its total liabilities (CN¥4.83 Billion) in one year. See 600422 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
KPC Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for KPC Pharmaceuticals Inc across 27 annual periods. For the full cash flow conversion analysis, see KPC Pharmaceuticals Inc (600422) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for KPC Pharmaceuticals Inc (1999–2025)
Year-by-year debt coverage analysis for KPC Pharmaceuticals Inc. Check 600422 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥289.24 Million | CN¥4.83 Billion | ▼ -56.6% |
| 2024 | 0.14x | CN¥808.07 Million | CN¥5.87 Billion | ▼ -20.7% |
| 2023 | 0.17x | CN¥754.33 Million | CN¥4.34 Billion | ▲ +193.6% |
| 2022 | 0.06x | CN¥253.90 Million | CN¥4.29 Billion | ▼ -7.0% |
| 2021 | 0.06x | CN¥251.63 Million | CN¥3.95 Billion | ▼ -45.3% |
| 2020 | 0.12x | CN¥409.94 Million | CN¥3.52 Billion | ▼ -15.9% |
| 2019 | 0.14x | CN¥429.50 Million | CN¥3.10 Billion | ▲ +15.8% |
| 2018 | 0.12x | CN¥352.07 Million | CN¥2.94 Billion | ▲ +26.5% |
| 2017 | 0.09x | CN¥242.53 Million | CN¥2.56 Billion | ▼ -45.6% |
| 2016 | 0.17x | CN¥311.16 Million | CN¥1.79 Billion | ▼ -41.2% |
| 2015 | 0.30x | CN¥476.62 Million | CN¥1.61 Billion | ▼ -24.0% |
| 2014 | 0.39x | CN¥379.13 Million | CN¥974.40 Million | ▲ +61.9% |
| 2013 | 0.24x | CN¥241.97 Million | CN¥1.01 Billion | ▲ +23.4% |
| 2012 | 0.19x | CN¥213.33 Million | CN¥1.10 Billion | ▼ -1.0% |
| 2011 | 0.20x | CN¥140.24 Million | CN¥712.37 Million | ▲ +29.2% |
| 2010 | 0.15x | CN¥90.82 Million | CN¥595.84 Million | ▼ -40.0% |
| 2009 | 0.25x | CN¥128.57 Million | CN¥505.79 Million | ▲ +35.0% |
| 2008 | 0.19x | CN¥91.59 Million | CN¥486.48 Million | ▼ -19.7% |
| 2007 | 0.23x | CN¥130.06 Million | CN¥554.98 Million | ▲ +108.3% |
| 2006 | 0.11x | CN¥61.25 Million | CN¥544.44 Million | ▲ +141.9% |
| 2005 | -0.27x | CN¥-174.52 Million | CN¥650.31 Million | ▼ -4235.1% |
| 2004 | -0.01x | CN¥-2.78 Million | CN¥448.75 Million | ▼ -102.9% |
| 2003 | 0.21x | CN¥61.23 Million | CN¥286.76 Million | ▲ +136.0% |
| 2002 | 0.09x | CN¥17.38 Million | CN¥192.11 Million | ▼ -72.4% |
| 2001 | 0.33x | CN¥67.07 Million | CN¥204.24 Million | ▲ +65.8% |
| 2000 | 0.20x | CN¥47.76 Million | CN¥241.15 Million | ▼ -3.3% |
| 1999 | 0.20x | CN¥60.24 Million | CN¥294.19 Million | — |